Found 287 with Last Name = 'szardenings' and Initial = 'ak' TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.0700nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.160nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.200nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.200nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.200nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.200nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.300nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: <0.300nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: <0.300nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: <0.300nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.340nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.380nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.380nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.400nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.400nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.5nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.560nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.600nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.630nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.700nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.780nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.800nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.900nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 0.900nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 1nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 1nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 1.10nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 1.10nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 1.30nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 1.30nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 1.30nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 1.60nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 1.60nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 2.20nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 2.5nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 3.10nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 3.10nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 3.40nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 3.80nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 4.10nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 5nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 6.60nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 6.60nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 6.60nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
3D Structure (crystal)TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 6.90nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 9.10nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 9.40nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 9.70nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 10.9nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
TargetGlutamate carboxypeptidase 2(Homo sapiens (Human))
Siemens Medical Solutions USA, Inc.
US Patent
Siemens Medical Solutions USA, Inc.
US Patent
Affinity DataKi: 12.5nMAssay Description:The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ...More data for this Ligand-Target Pair
